← FDA DRUG APPROVALS

FDA ANDA · ANDA206297

LIDOCAINE

Sponsor: AMNEAL PHARMS

APPLICATION
ANDA206297
TYPE
ANDA
ORIGINAL APPROVAL
2015-08-07
LATEST ACTION
2018-11-02
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

LIDOCAINEPrescription
LIDOCAINE 5% · OINTMENT · TOPICAL

Approval history

2018-11-02Labeling · Supplement 8 · standardAP
2018-04-09Labeling · Supplement 7 · standardAP
2017-06-20Manufacturing (CMC) · Supplement 5 · unknownAP
2017-06-20Manufacturing (CMC) · Supplement 3 · unknownAP
2017-06-20Labeling · Supplement 2 · standardAP
2015-08-07UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →